Latest news
Corticosteroids, RAS Inhibitors, or Sparsentan First for FSGS? - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 06 Aug 2026 13:56:38 GMTInside the DUPLEX Trial: FSGS Design, Endpoints, and Exclusions - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 06 Aug 2026 12:14:52 GMTFinerenone Shows Promise for Preserving Kidney Function in Glomerular Disease - Physician's WeeklyPhysician's Weekly · Sat, 01 Aug 2026 05:53:46 GMTFSGS Subtypes and Genetics: Why Classification Still Falls Short - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 30 Jul 2026 12:12:31 GMTFSGS Pathophysiology: Podocyte Injury Across the Lifespan - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 30 Jul 2026 12:12:31 GMT